Rhyme
PrivateLast Round
Series C
Feb 14, 2022
Total Funding Raised
$60.78M
Company Overview
Rhyme operates in Healthcare & Life Sciences and is based in New Albany, Ohio. Its latest recorded funding round was a Series C round in February 2022.
Rhyme is a healthcare technology company that provides an integrated prior authorization network platform to streamline communication between payors and providers.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Workflow Automation, RegTech
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhyme Comparables
Compare Rhyme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clinion | 86% | |
| Montrium | 84% | |
| Kivo | 84% |
For institutional investors. Book with your work email.
Rhyme Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 14, 2022 | ||||
| Series B | Oct 6, 2020 | ||||
| Series A | May 15, 2018 | ||||
| Seed | Aug 29, 2017 | ||||
| Seed | Apr 26, 2017 | ||||
Seed | Oct 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rhyme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Health2047 | Series C |
| BIP Capital | Series B, Series A |
| Rev1 Ventures | Seed |
| Detroit Venture Partners | Series A, Seed, Series B |
| NCT Ventures | Series A, Series B, Seed |
| Insight Partners | Series C, Series B |
| Panoramic Ventures | Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 14, 2022
$25M round led by Insight Partners
- Oct 6, 2020
$20M round led by Insight Partners.
For institutional investors. Book with your work email.
Rhyme Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rhyme's valuation, stock price, and market status.
Is Rhyme a public or private company?
Rhyme is a private company.
What is the current stock price of Rhyme?
Rhyme is a private company, so its shares have no public market price. Caplight tracks Rhyme's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rhyme worth (valuation)?
Valuation information for Rhyme is not publicly available.
Can I buy Rhyme stock?
Rhyme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rhyme's last funding round?
Rhyme's most recent funding round was Series C on February 14, 2022.
Who are the main investors in Rhyme?
Key investors in Rhyme include BIP Capital, NCT Ventures, Insight Partners, Panoramic Ventures.
Will Rhyme IPO soon?
No public IPO plans have been announced for Rhyme.
How can I track Rhyme secondary market activity?
Caplight tracks bids, offers, and trades in Rhyme's shares on secondary markets.